People: Clinton Names MIT Physicist To Influential OSTP Position

Later this month, the Senate is expected to confirm President Bill Clinton's June nomination of Ernest J. Moniz to be associate director for science of the Office of Science and Technology Policy (OSTP), under director and presidential science adviser John H. Gibbons. Currently head of the physics department at the Massachusetts Institute of Technology, Moniz, 50, will replace nutrition biologist M.R.C. Greenwood, who resigned in May for personal reasons and has returned to the University of Ca

Written byFranklin Hoke
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Working with Gibbons and Greenwood, Moniz was one of the principal framers of the administration's 1994 science policy report, "Science in the National Interest." The report was positively received by scientists as an expression of the administration's support for research and education, but was faulted for a lack of specifics concerning funding and the balance between basic and applied research (B. Reppert, The Scientist, Aug. 22, 1994, page 1).

Ernest Moniz LONG-TERM PLANNER: At OSTP, MIT's physics department head Ernest J. Moniz hopes to work with Congress to develop a science program that looks beyond current budget-cutting.

According to Moniz, the report was a solid endorsement by the administration for "investing" in basic science. Despite the prevailing budget-cutting orientation in Congress, Moniz sees a receptivity to this outlook on Capitol Hill.

"Through all the haze of contentious issues, the Congress has expressed a strong support for basic science research," Moniz notes. "There's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies